Developing a new method for male contraception using CatSper inhibitors
Catsper Inhibitors for Male Contraception
This study is looking for new ways for men to prevent pregnancy by finding safe compounds that can slow down sperm movement, making it easier to control when to have kids.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11016977 on NIH RePORTER |
What this research studies
This research focuses on creating a new form of male contraception by targeting the CatSper ion channel, which is essential for sperm function and male fertility. The study will involve screening various compounds to find those that can effectively inhibit CatSper, thereby reducing sperm motility and preventing pregnancy. Researchers will conduct tests to ensure these compounds are safe and effective, including assessing their pharmacokinetic properties and potential side effects. If successful, this approach could provide a reliable and reversible contraceptive option for men.
Who could benefit from this research
Good fit: Ideal candidates for this research are men who are seeking contraceptive options and are interested in participating in clinical trials.
Not a fit: Patients who are not interested in male contraception or those who have conditions affecting sperm production may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new, effective, and reversible male contraceptive method.
How similar studies have performed: Previous research has shown promise in targeting ion channels for contraception, but this specific approach using CatSper inhibitors is relatively novel.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Georg, Gunda I. — University of Minnesota
- Study coordinator: Georg, Gunda I.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.